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Accepted 9 April 2016The following case of a posterior fossa decompressionwith duraplasty illustrates the occurrence of a rare compli-
cation of the procedure. The percentage of these procedures that develop complications vary greatly, ranging
from 3–40% as is reported in the literature on the topic. Differences in complication rates between different
types of grafts vary in the literature as well, withmeta-analyses showing few signiﬁcant differences between dif-
ferent graft types. Epidural abscess however, is rarely if ever sited as a complication for either synthetic or biolog-
ical origin grafts. Additionally, the type of damage to the original bovine pericardium dural graft is rare as
complications of CSF leaks are almost always reported as stemming from the suture line of the graft, not from
damage to the center of the graft itself.Whether the complicationwas due to an inherent characteristic of the bo-
vine pericardium itself or an outlying factor of the procedure is unknown, but it is important to note that this rare
complication of an epidural abscess as well as the type of damage that caused the CSF leak is a possibility when
performing posterior fossa decompression with duraplasty.
© 2016 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Posterior fossa decompression (PFD) is the preferred treatment for
symptomatic Chiari Imalformation. There is currently somedebate regard-
ing speciﬁc aspects of the procedure such as when to use duraplasty with
the posterior fossa decompression and if duraplasty is used, which graft is
the most efﬁcacious and results in the lowest rate of complications. Com-
plications commonly associated among all graft types include CSF leakage,
pseudomeningocele, and aseptic meningitis. However, the following case
presents a posterior fossa decompression procedure for Chiari I malforma-
tion with a unique surgical complication, namely an epidural abscess.
2. Case report
A 29-year old male presented to the hospital with a one-year history
of progressive ataxia, nystagmus and intermittent headaches. MRI
showed a Chiari I malformation with cerebellar tonsil extension to the
top of C1 and some basilar impression. There was a pronounced syrinx
of the cervical spinal cord from C2 through C6. A suboccipital craniotomy
with C1 andC2 laminectomy andduraplastywas performed. Bovine peri-
cardium (Integra® Bovine Pericardium Dural Graft) was used and su-
tured to the existing dural leaﬂets. The patient tolerated the procedure
well but began to have postoperative complications three days laterWethington),
ail.com (A. Chamczuk),
pen access article under the CC BY-Nincluding a CSF leak and subcutaneous and epidural abscess. The abscess
was drained and debrided, blood and CSF cultures from this grew Entero-
bacteriaceae for which he was started on Meropenem. The former dural
patch was inspected at the time of surgery and showed intact suture
lines butmultiple tearswithin the center of the patch graft. Subsequently,
the former dural patch graftwas removed and replaced using an acellular
bovine collagenmatrix patch (DuraGen®). The patient tolerated this pro-
cedurewell andwas later dischargedwithhomehealthcare to administer
the remainder of the course of IV antibiotics.3. Discussion
Inmany cases, Chiari I malformation it is diagnosed in asymptomatic
or mildly symptomatic patients as an incidental ﬁnding on a MRI ac-
quired for another diagnostic purpose. As such, the true incidence of
Chiari I malformation is not known, but is estimated as occurring in
0.1 to 0.5% of the population. The most common presenting symptoms
include occipital or posterior cervical pain and headaches. Distortions
of the brainstem and cranial nerves leads to many of the other present-
ing symptoms such as upper motor neuron deﬁcits of weakness, senso-
ry abnormalities, hyperreﬂexia and/or lowermotor neuron deﬁcits such
as downbeating nystagmus, dysarthria, palatal weakness, sleep apnea
or recurrent aspiration [4].
Once diagnosed based on patient presentation and imaging, the
most common treatment of this disorder is posterior fossa decompres-
sion (PFD) via suboccipital craniotomy with or without duraplasty,
commonly combinedwith a C1 laminectomy. To date, there is a paucityC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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duraplasty should be used with PFD, or when PFD alone would be
sufﬁcient. Moreover, data is also lacking in respect to which dural
graft (if used) has the least risk of complication and the best clinical
outcome.
The most comprehensive meta-analysis to date involved a pediatric
sample and reported that PFDwith duraplasty had a signiﬁcantly lower
reoperation rate than PFD without duraplasty, but that it also had a
higher rate of CSF-related complications. However, there was no statis-
tically signiﬁcant difference in improvement in clinical outcomes [3].
The reporting of surgical complication rates is another challenge to
creating speciﬁc criterion in relation to the treatment of Chiari I malfor-
mation, as complication rates of the procedure vary widely from 3% to
42%, between individual centers and surgeons [5]. This variation in
complication rate makes it hard to generalize results to a wider popula-
tion, possibly contributing to the varying opinion of neurosurgeons in
regards to the questions of what the ideal amount of bony removal is,
when to use duraplasty and which materials are best [1]. A survey by
the American Association of Neurological Surgeons showed that the
preference of neurosurgeons as it relates to graft choice is varied:
32% preferred autologous pericranium, 32% bovine pericardium, 17%
cadaveric dura, 16% synthetic products and the remaining preferred
other materials [4]. This points to the fact that there is much variation
in management of Chiari I malformation, and not sufﬁcient evidence
to recommend one choice of technique or graft over another.
With non-autologous grafts there is a higher association of foreign
body reactions, adhesion formation, graft dissolution, excessive scaring
and bioﬁlm production. In addition, they tend to be associated with
higher rates of aseptic meningitis, pseudomeningocele formation, and
wound infection [5]. Autologous pericranium grafts are more likely to
be associated with complications such as reoperation and CSF leakage
[2]. The two nonautologous grafts used in the present case, bovine
pericardium and acellular bovine collagenmatrix (DuraGen) have similar
associated complications proﬁles as other biological based grafts
however, in theory the DuraGen graft may have lower rates of foreign
body reactions because of the acellular nature of the material. To date
however, no third party study has been conducted to show this.
There is currently no clear recommendation as to which type of
dural graft is the most efﬁcacious because different complications are
associated with different graft types. Although superﬁcial incisional
wound infections have been noted as complicationswith various grafts,epidural and subcutaneous abscesses such as that which presented in
the current case are rarely cited. In addition, the abnormal type and de-
gree of damage to the original bovine pericardium graft in the present
case was unlike that which is seen commonly with graft complications.
The present case showed intact suture lines but several tears through-
out the graft as a whole. Whether the foreign cellular nature of the bo-
vine pericardium graft played a role in the way the original dural graft
was damaged is unknown, but it is a possibility.
4. Conclusion
No prospective study has shown an inclusive comparison of the
differences in efﬁcacy between all dural grafts. The preference for
scope of the PFD procedure and choice of graft varies greatly between
providers. Although the majority of complications from PFD with
duraplasty do not include epidural abscesses nor do biological grafts
like bovine pericardium generally show the type of damage as was
seen in this particular case, it is important to be aware of rare complica-
tions such as these. This underscores the importance of continued vigi-
lance to both sterility of the operatingﬁeld aswell as patientmonitoring
post procedure for signs of complications such as these. Prospective
controlled studies of the differences in efﬁcacy of varied dural grafts or
case speciﬁc criterion of when duraplasty should be utilized with PFD
is needed to further increase the efﬁcacy and reduce the complication
rate for those patients with Chiari I malformation that undergo PFD.
The authors of this case report have no conﬂicts of interest to report
with the products described.
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